The ACTN3 R577X polymorphism is associated with inflammatory myopathies in a Mexican population

Scandinavian Journal of Rheumatology

Volumn 41, Issue 5, 2012, Pages 396-400

  Sandoval Garcia F ^a   Petri, M H ^a   Saavedra, M A ^b   Cruz Reyes, C V ^b   Jara Quezada, L J ^b   Davalos Rodriguez I P ^c,d   Salazar Paramo M ^a   Gamez Nava J I ^b   Gonzalez Lopez L ^b   Garcia Iglesias T ^a   Corona Sanchez E G ^a   Zavaleta Muniz S ^a   Vargas Ramirez R ^a   Mercado, M Vázquez Del ^a   Martin Marquez B T ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c University Centre of Health Sciences   (Mexico)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; LACTATE DEHYDROGENASE; MUSCLE ENZYME;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; MEXICO; MYOSITIS; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TISSUE LEVEL; WILD TYPE;

ACTININ; ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEXICO; MIDDLE AGED; MYOSITIS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 84867262246     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.669495     Document Type: Article

References (23)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
3. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Update on idiopathic inflammatory myopathies. Autoimmunity 2006;39: 161-70.
4. Weitoft T. Occurrence of polymyositis in the county of Gavleborg, Sweden. Scand J Rheumatol 1997;26:104-6.
5. Oddis CV, Conte CG, Steen VD, Medsger TA Jr. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990;17: 1329-34.
6. Shamim EA, Rider LG, Pandey JP, O'Hanlon TP, Jara LJ, Samayoa EA, et al. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. Arthritis Rheum 2002;46:1885-93.
7. Dixson JD, Forstner MJ, Garcia DM. The alpha-Actinin gene family: a revised classification. J Mol Evol 2003;56:1-10.
8. Holterhoff CK, Saunders RH, Brito EE, Wagner DS. Sequence and expression of the zebrafish alpha-Actinin gene family reveals conservation and diversification among vertebrates. Dev Dyn 2009;238:2936-47.
9. North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S, Beggs AH. A common nonsense mutation results in alpha-Actinin-3 deficiency in the general population. Nat Genet 1999;21:353-4.
10. North KN, Beggs AH. Deficiency of a skeletal muscle isoform of alpha-Actinin (alpha-Actinin-3) in merosin-positive congenital muscular dystrophy. Neuromuscul Disord 1996;6:229-35.
11. MacArthur DG, Seto JT, Raftery JM, Quinlan KG, Huttley GA, Hook JW, et al. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat Genet 2007;39:1261-5.
12. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 2003;73:627-31.
13. Moran CN, Yang N, Bailey ME, Tsiokanos A, Jamurtas A, MacArthur DG, et al. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur J Hum Genet 2007;15:88-93.
14. Lek M, Quinlan KG, North KN. The evolution of skeletal muscle performance: gene duplication and divergence of human sarcomeric alpha-Actinins. Bioessays 2010;32:17-25.
15. Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, Urso M, et al. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol 2005;99:154-63.
16. Clarkson PM, Hoffman EP, Zambraski E, Gordish-Dressman H, Kearns A, Hubal M, et al. ACTN3 and MLCK genotype associations with exertional muscle damage. J Appl Physiol 2005;99: 564-9.
17. Yang N,MacArthur DG, Wolde B, Onywera VO, BoitMK, Lau SY, et al. The ACTN3 R577X polymorphism in East and West African athletes. Med Sci Sports Exerc 2007;39:1985-8.
18. MacArthur DG, North KN. ACTN3: a genetic influence on muscle function and athletic performance. Exerc Sport Sci Rev 2007;35: 30-4.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
20. MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, Turner N, et al. An ACTN3 knockout mouse provides mechanistic insights into the association between alpha-Actinin-3 deficiency and human athletic performance. Hum Mol Genet 2008;17: 1076-86.
21. Delmonico MJ, Zmuda JM, Taylor BC, Cauley JA, Harris TB, Manini TM, et al. Association of the ACTN3 genotype and physical functioning with age in older adults. J Gerontol A Biol Sci Med Sci 2008;63:1227-34.
22. Seto JT, Chan S, Turner N, MacArthur DG, Raftery JM, Berman YD, et al. The effect of alpha-Actinin-3 deficiency on muscle aging. Exp Gerontol 2011;46:292-302.
23. Seto JT, Lek M, Quinlan KG, Houweling PJ, Zheng XF, Garton F, et al. Deficiency of alpha-Actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling. Hum Mol Genet 2011;20: 2914-27.